Clinical Trial to Assess the Efficacy and Safety of INNOCELL Immuncell-LC With Temozolomide in Newly Diagnosed Glioblastoma of Korea
| 針對症狀 | Glioblastoma |
| 臨床試驗編號 | NCT00807027 |
| 臨床階段 | Phase III |
| 臨床試驗位址 | 7 Study Locations |
| 目前研究進度 | This study has been completed. |
| 試驗開始日期 | December 10, 2008 |
| 試驗開始日期 | October 24, 2012 |
| 臨床目的 |
This clinical study was planned in order to assess the superiority of INNOCELL Corp. "Immuncell-LC" in aspects of therapeutic efficacy and safety when administered with Temozolomide to glioblastoma patients when compared with the control group who did not receive administration of the drug. |